"Legit" can mean two things: is this a real, accountable business, and is the medication any good? A web page can only help with the first. This page lists what NexLife publishes that you can check yourself, what we could not confirm, and where NexLife's own pages disagree.

What can you check about NexLife yourself?

Four things, each in a few minutes. The table shows what NexLife's pages say and where to confirm it.

NexLife checklist: what its pages state (terms read October 15, 2026; prices as of November 6, 2026) and how to confirm each item
CheckWhat NexLife's pages sayHow to confirm it
Named medical directorAdam Kennah, M.D.; care through NexLife Medical GroupLook up the license on the medical board site for your state and in the federal NPI Registry
Named pharmaciesAbsolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA), described as state-licensed 503A compounding pharmaciesSearch each name on the Florida, Alabama and Louisiana license lookups; ask which one will fill your prescription
Published pricesTirzepatide $129 month to month, down to $115 a month on 12 months; semaglutide $109, down to $95; same price at every dose; no memberships or contractsCompare the checkout total with the plan page before you pay
Written termsCancellation takes effect after 30 days; authorization charge refunded if not prescribed; shipped orders are final; a separate guarantee policy with conditionsSave dated copies of the plan page and the policy page when you enroll

Each item is a fact a regulator, a bank or you can test. A business that hides these details is harder to hold to account. A business that publishes them is not automatically a good one, but it gives you something to check.

How do you verify a compounding pharmacy's license?

Use the board of pharmacy in the state where the pharmacy is located, then check that it may ship to you. The steps:

  1. Open the license lookup for the home state: the Florida Department of Health's license verification portal for Absolute Pharmacy, the Alabama State Board of Pharmacy for Premium Compounding, and the Louisiana Board of Pharmacy for Boudreaux's New Drug Store.
  2. Search the exact business name and city. Note the license number, license type, status, expiration date and any public disciplinary action.
  3. Confirm the status reads active and the record matches the city NexLife lists.
  4. Check your own state's board for a nonresident pharmacy license, if your state requires one for pharmacies that ship to residents.
  5. When the medication arrives, read the label. The dispensing pharmacy named on it should be one of the three.

A 503A pharmacy compounds for individual prescriptions under state board oversight. That is a different category from an FDA-registered 503B outsourcing facility; our 503A vs 503B guide explains the difference and why it matters for compounded GLP-1s.

What did we not verify?

Where do NexLife's own pages disagree?

We found four conflicts on NexLife's pages, read October 15, 2026 and since:

Conflicts like these are common on sites that change prices often, and they are not proof of bad faith. They are a reason to get the price and refund terms that apply to you in writing before you pay.

What does NexLife's regulatory position mean for you?

NexLife sells compounded tirzepatide and semaglutide. They are made with the drugs in Zepbound and Wegovy, not the same products, and they are not FDA-approved. FDA proposed on April 30, 2026 not to place tirzepatide, semaglutide or liraglutide on the 503B bulks list; we found no final decision as of November 20, 2026. That proposal concerns outsourcing facilities, while NexLife's plan pages name 503A pharmacies that compound for individual prescriptions.

FDA has also acted against specific compounders. Its warning letter 738238 to Empower Pharmacy, dated September 18, 2026, said certain compounded tirzepatide and semaglutide combinations appeared to be essentially copies of approved products and cited insanitary conditions. Empower is not one of the three pharmacies NexLife names. See compounded vs brand GLP-1s for the wider picture.

How does this site relate to NexLife?

This site earns commissions; see the footer. NexLife is our editorial pick. Price check, November 20, 2026 reads, month to month: for tirzepatide Eden Health charges $129, Mondae $126 and Collective $85.58 with its yearly membership; for semaglutide Mondae charges $87, Eden $99 and Collective $75.58. That relationship is why the checklist above relies on records you can pull yourself rather than on our judgment. Our full NexLife review sets out the transparency checks, and the cancellation guide covers the refund terms in detail.

Frequently asked questions

Is NexLife a legitimate GLP-1 telehealth provider?

NexLife is a U.S. cash-pay telehealth program that, on pages we read through November 21, 2026, names its medical director (Adam Kennah, M.D.), names state-licensed 503A compounding pharmacies (three on its plan pages, two in its FAQ), and publishes prices, cancellation terms and a refund policy before checkout. FDA sent NexLife warning letter 730096 on June 8, 2026 about website claims; no close-out letter had been posted. Its compounded drugs are not FDA-approved, and GLPOneReview is affiliate-supported, so check the pharmacy licenses yourself before you pay.

Who is NexLife's medical director?

NexLife's pages name Adam Kennah, M.D., as medical director, with care delivered through NexLife Medical Group. A named physician is useful because you can check the license yourself: search the name on your state medical board's lookup and in the federal NPI Registry. A license record confirms the person is licensed; it does not tell you who will review your own intake, so ask that question during sign-up.

Which pharmacies fill NexLife prescriptions?

NexLife's plan pages name Absolute Pharmacy in Lutz, Florida, Premium Compounding in Decatur, Alabama, and Boudreaux's New Drug Store in Lake Charles, Louisiana, and describe them as state-licensed 503A compounding pharmacies. You can look each one up on its home state's board of pharmacy license search. When your order arrives, the pharmacy named on the label should match one of the three.

Did you check NexLife's LegitScript status?

No. We did not verify NexLife's LegitScript status during this review, so this site makes no claim about it either way. If that matters to you, check LegitScript's own public lookup directly. The checks we can stand behind are the ones in the table above: a named medical director, three named pharmacies, published prices and written cancellation and refund terms.

Does NexLife really offer a money-back guarantee?

A limited one. NexLife's guarantee policy page refunds program and membership fees, not medication, to members who enrolled on or after January 1, 2026, stayed 180 consecutive days without refill gaps, logged weight at least every two weeks, started at a BMI of 30 or more and lost less than 5% of starting weight, with the claim made between day 181 and day 210. The banner promising your money back on its microdose and ODT pages is broader than the policy.

Is NexLife's medication FDA-approved?

No. NexLife sells compounded tirzepatide and semaglutide, which are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality before sale. They are made with the drugs in Zepbound and Wegovy but are not the same products. If you want an FDA-approved medication, you would need a brand product such as Zepbound or Wegovy through a different program, insurance or a manufacturer's self-pay offer.

Sources

  1. NexLife: Compounded tirzepatide, all plans — pharmacy names, pharmacy type, terms read 2026-10-15; prices as of 2026-11-06
  2. NexLife: Compounded semaglutide, all plans — prices as of 2026-11-06; payment wording read 2026-10-15
  3. NexLife: Frequently asked questions — medical director, microdose ladder and payment wording read 2026-10-15
  4. NexLife: Guarantee (refund) policy — eligibility conditions and claim window read 2026-10-15
  5. NexLife: Microdose tirzepatide program — microdose prices read 2026-11-08 (equal to the standard plans); earlier tiles read 2026-10-15
  6. FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — content current as of 2026-10-01; read 2026-10-15
  7. FDA: Proposal not to include semaglutide, tirzepatide and liraglutide on the 503B bulks list — announced 2026-04-30 (91 FR 23431); no final decision found as of 2026-10-15
  8. FDA warning letter 738238: Empower Clinic Services, LLC dba Empower Pharmacy — dated 2026-09-18, posted 2026-09-22
  9. 16 CFR Part 465: Use of Consumer Reviews and Testimonials (eCFR) — staff guidance dated November 2024; rule effective 2024-10-21

Comparing programs? Check the all-in monthly price, the named pharmacy and the cancellation terms on the provider's own page before you pay.

Check NexLife's plans and state availability → See the price index

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.